Cargando…
Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells
Ulinastatin (UTI), a serine protease inhibitor, possesses anti-inflammatory properties and has been suggested to modulate lipopolysaccharide (LPS)-induced acute lung injury (ALI). High-mobility group box 1 (HMGB1), a nuclear DNA-binding protein, plays a key role in the development of ALI. The aim of...
Autores principales: | Luo, Yunpeng, Che, Wen, Zhao, Mingyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358699/ https://www.ncbi.nlm.nih.gov/pubmed/27959396 http://dx.doi.org/10.3892/ijmm.2016.2828 |
Ejemplares similares
-
Ulinastatin attenuates lipopolysaccharide-induced cardiac dysfunction by inhibiting inflammation and regulating autophagy
por: Zhao, Pin, et al.
Publicado: (2020) -
Ulinastatin alleviates pulmonary edema by reducing pulmonary permeability and stimulating alveolar fluid clearance in a rat model of acute lung injury
por: Jiang, Yuan-xu, et al.
Publicado: (2022) -
Ulinastatin ameliorates acute kidney injury following liver transplantation in rats and humans
por: LI, XIAOYUN, et al.
Publicado: (2015) -
Mitochondrial citrate accumulation drives alveolar epithelial cell necroptosis in lipopolysaccharide-induced acute lung injury
por: Yang, Hui-Hui, et al.
Publicado: (2022) -
Effect of ulinastatin on paraquat-induced-oxidative stress in human type II alveolar epithelial cells
por: Meng, Xiao-xiao, et al.
Publicado: (2013)